PROGRAMMIERBARE TYP-V-RNA-ENDONUKLEASESYSTEME
European patent · EP4352214 · In force
Register entry
- Publication number
- EP4352214
- Application number
- EP22733368
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 9, 2022
- Published
- Apr 17, 2024
- Granted
- Jul 8, 2026
- Protection ends at the latest
- Jun 8, 2042
- Next annual fee due
- Jun 30, 2027
- IPC classes
- C12N 9/22 (2006.01)C12N 15/55 (2006.01)C12N 15/11 (2006.01)
- Priority
- EP 21179011 11.06.2021EP 21196182 10.09.2021
- PCT application
- PCT/EP2022/065691 09.06.2022
- PCT publication
- WO2022/258753 15.12.2022
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 8, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 08.07.2026
Parties
Holder
Bayer Aktiengesellschaft
51373 Leverkusen, DE
Inventor
COHNEN, Andre
52445 Titz-Hasselsweiler, DE
RICHTER, Florian
50823 Köln, DE
KNYPHAUSEN, Philipp
50933 Köln, DE
NEERINCX, Andreas
51069 Köln, DE
MARKERT, Saskia Diana
50937 Köln, DE
BEDNARSKI, Christien
50825 Köln, DE
TURAN, Sören
50769 Köln, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.